WINTON GROUP Ltd Acquires New Shares in Waters Corporation $WAT

WINTON GROUP Ltd purchased a new stake in shares of Waters Corporation (NYSE:WAT) during the 4th quarter, Holdings Channel.com reports. The fund purchased 12,605 shares of the medical instruments supplier’s stock, valued at approximately $4,788,000.

A number of other institutional investors also recently bought and sold shares of the stock. Vise Technologies Inc. purchased a new stake in Waters in the 4th quarter worth $205,000. Daiwa Securities Group Inc. grew its position in Waters by 3.4% in the fourth quarter. Daiwa Securities Group Inc. now owns 12,723 shares of the medical instruments supplier’s stock worth $4,833,000 after acquiring an additional 414 shares in the last quarter. Cibc World Market Inc. grew its position in Waters by 7.5% in the fourth quarter. Cibc World Market Inc. now owns 6,930 shares of the medical instruments supplier’s stock worth $2,632,000 after acquiring an additional 484 shares in the last quarter. Anchor Capital Advisors LLC bought a new stake in Waters in the fourth quarter worth about $241,000. Finally, CIBC Asset Management Inc lifted its stake in Waters by 67.1% in the fourth quarter. CIBC Asset Management Inc now owns 14,368 shares of the medical instruments supplier’s stock worth $5,457,000 after purchasing an additional 5,771 shares during the last quarter. 94.01% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on WAT. Wall Street Zen downgraded shares of Waters from a “buy” rating to a “hold” rating in a research note on Sunday, February 8th. Robert W. Baird set a $387.00 price objective on shares of Waters in a research note on Wednesday, May 6th. Wolfe Research started coverage on shares of Waters in a research note on Tuesday, June 2nd. They issued an “outperform” rating and a $425.00 price objective for the company. HSBC lifted their price target on shares of Waters from $415.00 to $435.00 and gave the company a “buy” rating in a research note on Wednesday. Finally, TD Cowen lifted their price objective on shares of Waters from $345.00 to $385.00 and gave the company a “hold” rating in a report on Wednesday, May 6th. Three investment analysts have rated the stock with a Strong Buy rating, nine have issued a Buy rating and eight have issued a Hold rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $394.24.

Insider Activity

In related news, Director Wei Jiang acquired 500 shares of the stock in a transaction that occurred on Monday, March 16th. The stock was purchased at an average price of $289.46 per share, with a total value of $144,730.00. Following the transaction, the director owned 3,441 shares of the company’s stock, valued at approximately $996,031.86. This trade represents a 17.00% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at the SEC website. 0.31% of the stock is owned by corporate insiders.

Waters Trading Down 2.9%

NYSE WAT opened at $365.74 on Friday. The company has a fifty day moving average of $331.04 and a 200 day moving average of $350.91. The company has a market capitalization of $35.91 billion, a PE ratio of 46.47, a P/E/G ratio of 2.21 and a beta of 1.21. Waters Corporation has a 1 year low of $275.05 and a 1 year high of $414.15. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.79 and a quick ratio of 1.13.

Waters (NYSE:WAT) last released its quarterly earnings results on Tuesday, May 5th. The medical instruments supplier reported $2.70 earnings per share for the quarter, topping the consensus estimate of $2.31 by $0.39. The firm had revenue of $1.27 billion during the quarter, compared to the consensus estimate of $1.20 billion. Waters had a net margin of 11.91% and a return on equity of 15.60%. The company’s revenue for the quarter was up 91.4% on a year-over-year basis. During the same quarter in the prior year, the firm earned $2.25 EPS. Waters has set its Q2 2026 guidance at 2.950-3.050 EPS and its FY 2026 guidance at 14.400-14.600 EPS. Research analysts forecast that Waters Corporation will post 14.5 earnings per share for the current year.

Waters Company Profile

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.